Lsv Asset Management’s Gilead Sciences Inc Position
Does Lsv Asset Management own Gilead Sciences Inc (GILD)? Yes — 2.89M shares worth $403M (+0.87% of its 13F portfolio) as of Q1 2026, down from 4.15M shares the prior filed quarter.
Position Value
$403M
Q1 2026
Shares
2.89M
% of Portfolio
+0.87%
Quarters Held
30
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.89M | $403M | +0.87% |
| Q4 2025 | 4.15M | $509M | +1.11% |
| Q3 2025 | 4.30M | $477M | +1.05% |
| Q2 2025 | 4.52M | $501M | +1.17% |
| Q1 2025 | 4.92M | $551M | +1.32% |
| Q4 2024 | 5.03M | $464M | +1.07% |
| Q3 2024 | 5.29M | $443M | +0.95% |
| Q2 2024 | 5.51M | $378M | +0.83% |
| Q1 2024 | 5.68M | $416M | +0.86% |
| Q4 2023 | 5.93M | $480M | +1.05% |
| Q3 2023 | 6.14M | $460M | +1.07% |
| Q2 2023 | 6.29M | $485M | +1.07% |
| Q1 2023 | 6.48M | $538M | +1.21% |
| Q4 2022 | 6.57M | $564M | +1.24% |
| Q3 2022 | 6.68M | $412M | +0.97% |
| Q2 2022 | 6.55M | $405M | +0.87% |
| Q1 2022 | 5.55M | $330M | +0.61% |
| Q4 2021 | 5.10M | $371M | +0.66% |
| Q3 2021 | 4.33M | $303M | +0.55% |
| Q2 2021 | 4.16M | $287M | +0.49% |
| Q1 2021 | 4.19M | $271M | +0.46% |
| Q4 2020 | 4.39M | $256M | +0.46% |
| Q3 2020 | 4.58M | $290M | +0.59% |
| Q2 2020 | 4.51M | $347M | +0.72% |
| Q1 2020 | 4.50M | $336M | +0.81% |
| Q4 2019 | 4.59M | $298M | +0.46% |
| Q3 2019 | 4.53M | $287M | +0.48% |
| Q2 2019 | 4.66M | $315M | +0.51% |
| Q1 2019 | 4.69M | $305M | +0.49% |
| Q4 2018 | 4.65M | $291M | +0.52% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lsv Asset Management’s full portfolio or all institutional holders of GILD.